- cafead Apr 24, 2023 at 12:02: PM
via Research and development (R&D) spending by drug manufacturers flatlined in 2022, according to data released by Evaluate Vantage Friday morning.
Among the world’s largest 11 drugmakers, only AstraZeneca and Sanofi showed any “real uptick” in R&D investment, as the urgency to develop treatments for COVID-19 fell by the wayside.
article source
Among the world’s largest 11 drugmakers, only AstraZeneca and Sanofi showed any “real uptick” in R&D investment, as the urgency to develop treatments for COVID-19 fell by the wayside.
article source